Journal: |
The Egyptian Journal of Chest Diseases and Tuberculosis
The Egyptian Journal of Chest Diseases and Tuberculosis
|
Volume: |
|
Abstract: |
Venovenous extracorporeal membrane oxygenation (VV-ECMO) should be
considered when conventional mechanical ventilation failed to maintain
adequate gas exchange. ECMO improved gas exchange and thus preventing
hypoxia and ventilator-induced lung injury.
Aim
To compare between VV-ECMO and conventional mechanical ventilatory support
with protective lung strategy in patients with acute respiratory distress syndrome
regarding selection of patients, efficacy, complications, and outcome.
Patients and methods
We retrospectively studied 83 patients referred for VV-ECMO consideration to
ECMOcenter in the ICU in Chest Disease Hospital in Kuwait between January 2015
and October 2018. We had two groups: ECMO group (N=38) and conventional
mechanical ventilation group (control group) (N=45). We excluded from ECMO all
patients with contraindication to ECMO. After 7 days, five patients shifted to rescue
ECMO owing to worsening of their condition. Clinical, laboratory, ventilator
parameters, complications, and survival rate were compared between both groups.
Result
The clinical, laboratory, and ventilator parameters of the patients on randomization
were very bad for both groups. After 5 days, significant improvement was recorded
among ECMO group. At the end point of the study, weaning from ECMO was
successful in 32 (74.4%) of the 43 patients, whereas in the control group, 28 (70%)
patients were weaned successfully. Mortality was nonsignificantly higher in the
control group (30 vs. 25.6% for ECMO group). The most common fatal complication
among ECMO group was bleeding (63.6%), whereas it was respiratory failure
among the control group (75%). Advanced age, long duration of mechanical
ventilation before ECMO, immunocompromised state, higher blood lactate level
and higher Acute Physiology and Chronic Health Evaluation II score, and the
underlying lung disease before ECMO were associated with poor outcome.
Conclusion
VV-ECMO can be considered as an alternative therapy for patients with severe but
potentially reversible acute respiratory distress syndrome when conventional
ventilation failed. ECMO reduced the risk of ventilator-induced lung injury.
ECMO significantly improved most of the clinical, laboratory, and ventilator
parameters within days after ECMO application. ECMO had more favorable
outcome and lower rate of mortality but with higher complications
|
|
|